Pulmonary sarcoidosis: Management

Journal of Postgraduate Medicine

Volumn 48, Issue 2, 2002, Pages 135-141

  Sharma, Om P ^a  

^a LAC USC MEDICAL CENTER   (United States)

Author keywords

Pulmonary sarcoidosis treatment; Sarcoidosis management

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CHLOROQUINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOTOXIC AGENT; FOLIC ACID; HYDROXYCHLOROQUINE; IMMUNOMODULATING AGENT; INFLIXIMAB; KETOCONAZOLE; MERCAPTOPURINE; MESNA; METHOTREXATE; MONOCLONAL ANTIBODY; OXYPHENBUTAZONE; PENTOXIFYLLINE; PLACEBO; PREDNISOLONE; PREDNISONE; RECEPTOR BLOCKING AGENT; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ALLERGIC PNEUMONITIS; ALOPECIA; ARTICLE; BLADDER DISEASE; BONE MARROW TOXICITY; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DEMENTIA; DRUG CLEARANCE; EXPOSURE; EYE TOXICITY; GASTROINTESTINAL SYMPTOM; GENETIC PREDISPOSITION; GRANULOMA; HEMORRHAGIC CYSTITIS; HISTOPATHOLOGY; HUMAN; HYPERTENSION; KIDNEY FAILURE; LIVER INJURY; RADIOGRAPHY; SARCOIDOSIS; SIDE EFFECT; SYSTEMIC DISEASE;

ADRENAL CORTEX HORMONES; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; PROGNOSIS; RADIOTHERAPY; SARCOIDOSIS, PULMONARY; TREATMENT OUTCOME;

EID: 0036526402     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. ATS/ERS/WASOG Statement on Sarcoidosis
2. Diagnosis, pathogenesis, and treatment of Sarcoidosis
3. Do measurements of bronchoalveolar lavage lymphocytes, neutrophils, serum angiotensin converting enzyme and gallium uptake help the clinician to treat patients with sarcoidosis?
4. Pulmonary sarcoidosis: Evaluation with high-resolution CT
5. Sarcoidosis: Correlation of pulmonary parenchymal pattern at CT with results of pulmonary function tests
6. Computed tomography in pulmonary sarcoidosis
7. The detection of recurrent sarcoidosisin a lung transplant recipient
8. Mortality of Intrathoracic Sarcoidosis in Referral vs Population based settings: Influence of stage, ethnicity, and corticosteroid therapy
9. The natural history of pulmonary sarcoidosis
10. Effects of cortisone in sarcoidosis: A study of thirteen patients
11. Effect of 18-month corticosteroid therapy on the Stage I and Stage II sarcoidosis patients
12. Clinical and functional results of a controlled clinical trial of the value of prednisolone therapy in sarcoidosis, Stage I and II
13. A ten-year study of corticosteroid treatment of pulmonary sarcoidosis
14. Presentation of sarcoidosis and outcome of pulmonary changes
15. Course of pulmonary sarcoidosis with and without corticosteroid therapy as determined by pulmonary function studies
16. Pulmonary sarcoidosis: A prospective evaluation of glucocorticoid therapy
17. A controlled trial of prednisone treatment of sarcoidosis
18. Early treatment of Stage II sarcoidosis improves 5-year pulmonary function
19. Of time and experience: Sarcoidosis revisited
20. Treatment with steroids
21. Outcome of the treatment of sarcoidosis
22. Outcome in sarcoidosis: The relationship of relapse to corticosteroid therapy
23. Inhaled corticosteroids and pulmonary sarcoidosis
24. Inhaled corticosteroids can modulate the immunopathogenesis of pulmonary sarcoidosis
25. The use of low-dose methotrexate in refractory sarcoidosis
26. Steroid sparing alternative treatments for sarcoidosis
27. Chloroquine therapy in 43 patients with intrathoracic and cutaneous sarcoidosis
28. Effective reduction in the serum 1,25-dyhydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy
29. Visual function and long-term chloroquine treatment
30. Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement
31. Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders
32. Efficacy of Azathioprine as second line treatment in Pulmonary Sarcoidosis
33. Long-term use of azathioprine as a steroid-sparing treatment for chronic sarcoidosis
34. Chlorambucil in sarcoidosis
35. Fatal herpes simplex infection during chlorambucil therapy for sarcoidosis
36. Identification of patients with sarcoidosis at risk for death from respiratory failure
37. Therapeutic considerations in the patients with refractory neurosarcoidosis
38. Cyclosporine
39. Ketoconazole decreases the serum 1-25 dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia
40. Ketoconazole for the treatment of refractory hypercalcemia in sarcoidosis
41. Neurosarcoidosis associated with hypersomnolence treated with corticosteroids and brain irradiation
42. Total nodal radiation in progressive sarcoidosis. Case report
43. Treatment modalities for sarcoidosis
44. Further observation with thalidomide in lepra reaction
45. Inhibition of IL-12 production by thalidomide
46. Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes
47. Thalidomide reduces tumor necrosis factor-alpha production by human alveolar macrophages
48. Treatment of cutaneous and pulmonary sarcoidosis with thalidomide
49. Pentoxifylline exerts synergistic immunomodulatory effects in combination with dexamethasone or cyclosporine
50. Pentoxifylline in treatment of sarcoidosis
51. Infliximab for refractory sarcoidosis
52. Combination therapy for sarcoidosis